15
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10488 | BCR-ABL-IN-1 | Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
BCR-ABL-IN-1 is a BCR-ABL tyrosine kinase inhibitor (pIC50: 6.46) and may be used in the research of chronic myelogenous leukemia. | |||
T11916 |
Lyn-IN-1
巴非替尼,Bafetinib analog |
Bcr-Abl; Src | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Lyn-IN-1 (Bafetinib analog) 是一种高活性 Bcr-Abl 和 Lyn 双重抑制剂。 | |||
T64338 |
AKI603
AKI 603,AKI-603 |
Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
AKI603 是一种极光激酶 A 抑制剂,IC50值为 12.3 nM。它对白血病细胞具有很强的抗增殖活性,可用于克服白血病中 BCR-ABL-T315I 耐药性突变。 | |||
T21785 |
AG957
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG957 是一种酪氨酸激酶抑制剂,具有抗BCR/ABL 酪氨酸激酶活性。它能够抑制p210bcr/abl 酶活性 (IC50:2.9 μM)。 | |||
T37600 | Dasatinib N-oxide | Others | Others |
Dasatinib N-oxide 是 Dasatinib 的一种次要代谢物。Dasatinib 是口服有效的 Src/Bcr-Abl 抑制剂。 | |||
T82909 |
BCR-ABL-IN-8
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
BCR-ABL-IN-8(化合物26f)是一种具有三甲氧基基团(trimethoxy group)的BCR-ABL抑制剂。 | |||
T11977 | Mcl1-IN-9 | BCL | Apoptosis |
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. | |||
T77969 |
SIAIS100 TFA
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
SIAIS100 TFA是一款高效的BCR-ABL PROTAC降解剂,其DC50值为2.7 nM,主要应用于慢性粒细胞白血病(CML)的研究。 | |||
T77974 |
PROTAC BCR-ABL Degrader-1
|
PROTACs | PROTAC |
PROTACBCR-ABLDegrader-1(化合物PROTAC1)是一种含有2-oxoethyl linker的PROTAC。该化合物能通过泛素蛋白酶体(ubiquitinproteasom)系统诱导Bcr-Abl的降解,并对K562细胞表现出抗增殖效果,显示出其在癌症研究中的应用潜力。 | |||
T71313 |
BVB-808
|
||
BVB-808 is a selective Jak2 type 1 inhibitor. Janus kinases are critical components of signaling pathways that regulate hematopoiesis. Mutations of the non-receptor tyrosine kinase JAK2 are found in many BCR-ABL-negative myeloproliferative neoplasms. Preclinical results support that JAK2 inhibitors could show efficacy in treating chronic myeloproliferative neoplasms. JAK2 has also been postulated to play a role in BCR-ABL signal transduction. Therefore, inhibitors of JAK2 kinases are turning int... | |||
T61324 |
BCR-ABL1-IN-1
|
||
BCR-ABL1-IN-1 is a highly potent and orally bioavailable inhibitor, displaying remarkable specificity towards ABL kinase. Notably, this compound holds significant promise for delineating the precise involvement of ABL kinases within the central nervous system, particularly in preclinical investigations [1]. | |||
T18694 |
SNIPER(ABL)-050
|
Others | Others |
SNIPER(ABL)-050 is a chemical compound that combines Imatinib, an ABL inhibitor, with MV-1, an IAP ligand, using a linker. This conjugation results in the reduction of BCR-ABL protein[1]. | |||
T75012 | SIAIS100 | ||
SIAIS100 是一种有效的BCR-ABLPROTAC 降解剂,DC50为 2.7 nM。SIAIS100 可用于研究慢性粒细胞白血病 (CML)。 | |||
T73973 | Imatinib Impurity E | ||
Imatinib Impurity E 是 Imatinib 的杂质。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂,可选择性抑制 BCR/ABL,v-Abl,PDGFR,c-kit 激酶活性。Imatinib (STI571) 靠近 ATP 结合位点结合,将其锁定在封闭或自我抑制的构象中,因此半竞争性抑制蛋白质的酶活性。Imatinib 还抑制 SARS-CoV 和MERS-CoV。 | |||
T36578 |
Boc-Lys(Ac)-AMC
|
||
Commendamide (N-acyl-3-hydroxypalmitoyl-glycine) is a newly discovered GPCR G2A/GPR132 agonist (EC50=11.8 μM) that isolated from Bacteroides vulgatus. [1] G2A/GPR132 belongs to the guanine nucleotide-binding protein (G protein)-coupled receptor (GPCR) superfamily. GPR132/G2A is first reported to be a transcriptional target for BCR-ABL tyrosine kinase attenuating B-cell expansion in vitro and arresting cells at G2 during mitosis. It has been involved in autoimmune disease and atherosclerosis. [1]... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3S1553 |
trans-Cinnamaldehyde
Cinnamaldehyde,Cinnamic aldehyde,桂皮醛,反式肉桂醛,Cinnamal,Phenylacrolein |
COX; Endogenous Metabolite | Immunology/Inflammation; Metabolism; Neuroscience |
trans-Cinnamaldehyde (Phenylacrolein) 是一种能够用于合成反式肉桂醛-β-环糊精复合物,一种能够食用的抗菌涂层,能够延长鲜切水果的保质期。它是一种能够通过烷基异氰化物与乙炔二羧酸二烷基酯的反应来合成高度多官能的呋喃环。 |